Characteristics | Baseline | 24 Weeks |
Age (years) | 53.9 (13.5) | |
Women (%) | 72.1 | |
Disease duration (years) | 7.6 (9.1) | |
Years of education | 11.8 (3.1) | |
Rheumatoid factor (%) | 65.1 | |
Erosive disease (%) | 51.3 | |
With satisfactory condition (%) | 40.9 | 63.2 |
Composite indices | ||
DAS28 | 4.98 (1.36) | 3.71 (1.51) |
SDAI | 27.6 (14.0) | 16.0 (12.5) |
CDAI | 24.9 (12.9) | 14.5 (11.7) |
PAS | 4.76 (2.02) | 3.43 (2.01) |
Global scales, pain and fatigue | ||
Investigator global VAS | 40.3 (17.7) | 22.2 (17.3) |
Patient global VAS | 51.2 (23.5) | 35.9 (23.9) |
Joint pain VAS | 48.1 (24.0) | 33.1 (23.3) |
Fatigue VAS | 48.5 (28.4) | 39.6 (27.4) |
Functional measures | ||
MHAQ | 1.71 (0.51) | 1.48 (0.45) |
HAQ | 1.31 (0.61) | 1.02 (0.56) |
SF-36 | ||
Physical | 48.5 (24.1) | 58.3 (25.1) |
Bodily pain | 32.7 (17.0) | 46.8 (20.9) |
General health | 49.8 (19.9) | 53.9 (21.4) |
Vitality | 38.5 (20.8) | 47.3 (21.7) |
Social function | 63.7 (25.8) | 73.4 (23.6) |
Mental | 70.6 (18.2) | 75.4 (17.3) |
Mean (SD) for continuous variables, % for categorical values.
CDAI, Clinical Disease Activity Index; DAS28, 28-joint Disease Activity Score; HAQ, Health Assessment Questionnaire; MHAQ, modified Health Assessment Questionnaire; PAS, Patient Activity Scale; SDAI, Simplified Disease Activity Index; SF-36, Short Form-36; VAS, visual analogue scale (mm).